SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

03 Feb 2023 Evaluate
A fair growth of 14.02% in the revenue at Rs. 20869.00 millions was reported in the December 2022 quarter as compared to Rs. 18303.00 millions during year-ago period.A good growth in profit of 29.90% reported to Rs. 2559.00  millions over Rs. 1970.00 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 5949.00 millions from 3845.00 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 20869.00 18303.00 14.02 64666.00 59626.00 8.45 79819.00 77800.00 2.60
Other Income 1363.00 259.00 426.25 2972.00 1250.00 137.76 1787.00 893.00 100.11
PBIDT 5949.00 3845.00 54.72 19791.00 15855.00 24.82 20968.00 23980.00 -12.56
Interest 885.00 246.00 259.76 1932.00 929.00 107.97 1349.00 709.00 90.27
PBDT 5064.00 3599.00 40.71 17859.00 11733.00 52.21 16426.00 21396.00 -23.23
Depreciation 1216.00 1200.00 1.33 3687.00 3559.00 3.60 4787.00 4511.00 6.12
PBT 3848.00 2399.00 60.40 14172.00 8174.00 73.38 11639.00 16885.00 -31.07
TAX 1289.00 429.00 200.47 3787.00 2064.00 83.48 3060.00 2123.00 44.14
Deferred Tax 427.00 183.00 133.33 465.00 241.00 92.95 458.00 -910.00 -150.33
PAT 2559.00 1970.00 29.90 10385.00 6110.00 69.97 8579.00 14762.00 -41.88
Equity 1012.00 1024.00 -1.17 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 28.51 21.01 35.70 30.60 26.59 15.10 26.27 30.82 -14.77

Zydus Lifesciences Share Price

940.70 -1.85 (-0.20%)
20-Apr-2026 11:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.30
Dr. Reddys Lab 1237.10
Cipla 1236.85
Zydus Lifesciences 940.70
Lupin 2335.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×